- Home
- ANEB vs LUCD Comparison
ANEB vs LUCD Comparison
Compare ANEB & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- LUCD
- Stock Information
- Founded
- ANEB 2020
- LUCD 2018
- Country
- ANEB United States
- LUCD United States
- Employees
- ANEB N/A
- LUCD N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ANEB Health Care
- LUCD Health Care
- Exchange
- ANEB Nasdaq
- LUCD Nasdaq
- Market Cap
- ANEB 36.7M
- LUCD 38.4M
- IPO Year
- ANEB 2021
- LUCD 2021
- Fundamental
- Price
- ANEB $1.46
- LUCD $1.00
- Analyst Decision
- ANEB Buy
- LUCD Strong Buy
- Analyst Count
- ANEB 1
- LUCD 4
- Target Price
- ANEB $8.00
- LUCD $3.69
- AVG Volume (30 Days)
- ANEB 6.3K
- LUCD 532.8K
- Earning Date
- ANEB 11-13-2024
- LUCD 11-13-2024
- Dividend Yield
- ANEB N/A
- LUCD N/A
- EPS Growth
- ANEB N/A
- LUCD N/A
- EPS
- ANEB N/A
- LUCD N/A
- Revenue
- ANEB N/A
- LUCD $4,189,000.00
- Revenue This Year
- ANEB N/A
- LUCD $88.47
- Revenue Next Year
- ANEB N/A
- LUCD $238.94
- P/E Ratio
- ANEB N/A
- LUCD N/A
- Revenue Growth
- ANEB N/A
- LUCD 179.27
- 52 Week Low
- ANEB $1.25
- LUCD $0.63
- 52 Week High
- ANEB $3.30
- LUCD $1.58
- Technical
- Relative Strength Index (RSI)
- ANEB 36.57
- LUCD 57.67
- Support Level
- ANEB $1.25
- LUCD $0.90
- Resistance Level
- ANEB $1.68
- LUCD $1.12
- Average True Range (ATR)
- ANEB 0.16
- LUCD 0.06
- MACD
- ANEB -0.01
- LUCD -0.01
- Stochastic Oscillator
- ANEB 30.00
- LUCD 45.00
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.